Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-25 Purchase | 2023-09-25 4:34 pm | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 10,000 | $0.86 | $8,600 | 3,585,562 (Indirect Direct) | View |
| 2022-12-21 Purchase | 2022-12-21 4:26 pm | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 14,000 | $1.019 | $14,266 | 3,575,562 (Indirect Direct) | View |
| 2021-02-10 Sale(A) | 2022-12-19 7:40 pm | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 32,873 | $4.43 | $145,627 | 4,951,547 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-17 9:06 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 36,695 | $2.8454 | $104,411 | 1,559,030 (Indirect Direct) | View |
| 2022-03-28 Purchase | 2022-03-28 4:44 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 3,000 | $7.2014 | $21,604 | 1,522,335 (Indirect Direct) | View |
| 2022-01-11 Purchase | 2022-01-11 9:20 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 265,000 | $14 | $3,710,000 | 1,519,335 (Indirect) | View |
| 2021-08-18 Purchase | 2021-08-18 6:07 pm | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 10,000 | $3 | $30,000 | 32,943 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 5:22 pm | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 32,873 | $4.43 | $145,627 | 3,441,521 (Indirect Direct) | View |
| 2020-11-23 Purchase | 2020-11-24 4:04 pm | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 5,000 | $3.602 | $18,010 | 22,943 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:28 pm | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director 10% Owner | 2,908 | $14 | $40,712 | 415,959 (Indirect) | View |
| 2019-06-18 Sale | 2019-06-20 7:09 pm | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director 10% Owner | 400 | $14 | $5,600 | 416,418 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-23 4:41 pm | N/A 2033-06-21 | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-05-19 Exercise | 2023-05-19 4:18 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 3,750 | $0 | 3,581,733 (Direct) | View |
| 2022-12-15 Other | 2022-12-19 7:41 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 1,415,029 | $0 | 4,976,591 (Indirect) | View |
| 2022-06-22 Option Award | 2022-06-24 4:21 pm | N/A 2032-06-21 | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 4:46 pm | N/A 2032-05-18 | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-11 9:20 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 4,732,862 | $0 | 1,519,335 (Indirect) | View |
Ownership | 2022-01-06 8:34 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 0 | $0 | 1,254,335 (Indirect) | View |
| 2021-06-10 Option Award | 2021-06-11 5:33 pm | N/A 2031-06-09 | Clearside Biomedical Inc. | CLSD | Thorp Clay Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 6:03 pm | N/A 2031-06-03 | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2020-11-16 Other | 2020-11-18 7:19 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 65,127 | $0 | 2,495,989 (Indirect) | View |
| 2020-06-18 Option Award | 2020-06-19 4:41 pm | N/A 2030-06-17 | Clearside Biomedical Inc. | CLSD | Thorp Clay Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 7:02 pm | N/A 2030-06-03 | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2019-11-22 Option Award | 2019-11-26 4:33 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | Thorp Clay Director 10% Owner | 1,518,026 | $1.054 | 4,992,420 (Indirect) | View |
| 2019-06-20 Option Award | 2019-06-24 4:29 pm | N/A 2029-06-19 | Clearside Biomedical Inc. | CLSD | Thorp Clay Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-13 4:35 pm | N/A 2029-05-09 | PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director 10% Owner | 11,000 | $0 | 11,000 (Direct) | View |